Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
Jones
R
R
Franklin
K
K
Spicer
R
R
Berry
J
J
D000464:Alginates / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000681:Amylases / Q000009:adverse effects*; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001963:Bromelains / Q000009:adverse effects*; D020117:Cisapride; D003106:Colon / Q000473:pathology; D003108:Colonic Diseases / Q000139:chemically induced* / Q000473:pathology; D003251:Constriction, Pathologic / Q000139:chemically induced; D003550:Cystic Fibrosis / Q000150:complications*; D004338:Drug Combinations; D006801:Humans; D007223:Infant; D007413:Intestinal Mucosa / Q000473:pathology; D007415:Intestinal Obstruction / Q000139:chemically induced* / Q000473:pathology; D008049:Lipase / Q000009:adverse effects*; D008297:Male; D010880:Piperidines / Q000627:therapeutic use; D012824:Silicic Acid / Q000627:therapeutic use; D017693:Sodium Bicarbonate / Q000627:therapeutic use; D014357:Trypsin / Q000009:adverse effects*
D000464:Alginates; D000863:Antacids; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; C002762:Nutrizym; D010880:Piperidines; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D017693:Sodium Bicarbonate; D001963:Bromelains; D008049:Lipase; D000681:Amylases; D014357:Trypsin; D020117:Cisapride